This article discusses the use of flow cytometry MRD (minimal residual disease) testing for detecting impending relapse in patients with acute myeloid leukemia (AML).…
Browsing: AML
Napier AI, a London-based RegTech company, has partnered with Salt Bank, the first Romanian neobank, to provide its award-winning Transaction Screening product in a…
Napier AI, a London-based financial crime compliance RegTech, has partnered with Salt Bank, the first Romanian neobank, to provide its Transaction Screening product in…
Napier AI has been selected as the anti-money laundering platform for Salt Bank, the first Romanian neobank. The collaboration will enable Salt Bank to…
The global AML market is expected to grow significantly due to the increased adoption of AI and ML technologies in developing AML solutions. Companies…
Antengene recently announced the approval of XPOVIO® in Macau for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML). According…